Table 2: Epigenetic modifier drugs in noncancer clinical trials (partial list).

DrugDiseaseNCT numberPhase

5-AzacitidineBeta thalassemiaNCT00005934Phase 2
5-Azacytidine + Na phenylbutyrateThalassemia majorNCT00007072Phase 2
ResveratrolCardiovascular diseasesNCT01449110Phase 2
ResveratrolTraumaNCT01321151Phase 1
ResveratrolMetabolic syndrome, obesityNCT01150955Phase 1
CurcuminIrritable bowel syndromeNCT00779493Phase 4
CurcuminAlzheimer diseaseNCT00164749Phase 2
CurcuminPsoriasisNCT00235625Phase 2